Skip to main content
. Author manuscript; available in PMC: 2022 Oct 6.
Published in final edited form as: Lancet HIV. 2022 Jul 28;9(9):e607–e616. doi: 10.1016/S2352-3018(22)00166-7

Figure 1: Trial profile.

Figure 1:

*Two managers (one district health officer and one tuberculosis supervisor) per district. In one district, one manager (district health officer) declined to participate, but this manager’s district was represented by the tuberculosis supervisor. †Three districts were divided, creating three new districts. ‡One district was divided, creating one new district. §One district was excluded due to lack of data for primary and secondary outcomes.